The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of intraperitoneal IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer administered in combination with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, Fallopian tube, or primary peritoneal cancer patients: An NRG/GOG study.
 
Premal H. Thaker
Consulting or Advisory Role - Celsion; Incyte
 
William E Brady
No Relationships to Disclose
 
William Hampton Bradley
No Relationships to Disclose
 
Khursheed Anwer
Employment - Celsion; EGEN
Stock and Other Ownership Interests - Celsion
Patents, Royalties, Other Intellectual Property - EGEN
 
Ronald David Alvarez
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Celsion/EGEN; Genentech/Roche; GlaxoSmithKline; Janssen Oncology; Vermillion
Research Funding - Merrimack; Morphotek; Pfizer